Purification Insights

Technical knowledge, made visual.

Explore practical, science-based visual insights across downstream bioprocessing—from molecular fundamentals to process development and manufacturing.

Molecules & Modalities

Biologic structures, therapeutic modalities, molecular properties, stability, and purification implications.

MOLECULES & MODALITIES

Mammalian Expression Systems

Mammalian cells are widely used for complex biologics because they support proper folding and human-like post-translational modifications. Their downstream processes must address diverse HCPs, DNA, aggregates, and product-related variants.

MOLECULES & MODALITIES

Microbial Expression Systems

Microbial hosts offer rapid growth, high productivity, and relatively simple cultivation, but often create very different purification challenges. Cell disruption, endotoxin, nucleic acids, inclusion bodies, and high HCP loads can strongly shape the downstream strategy.

MOLECULES & MODALITIES

Viral Vector and Viral-based Products

Viral and insect-cell platforms are commonly used for viral vectors, vaccines, and complex recombinant products. Purification must balance product recovery with removal of host-cell impurities, nucleic acids, empty or defective particles, and process-derived contaminants.

Poster placeholder

MOLECULES & MODALITIES

Title

Coming soon..

Chromatography

Affinity, ion exchange, HIC, SEC, multimodal media, resin selection, mass transfer, and column operation.

CHROMATOGRAPHY

Chromatography Resin Ligands I

Chromatography resin performance is fundamentally governed by ligand chemistry.

hashtag#Part_1 highlights how ligand structure and surface functionality define the core behavior of affinity and ion exchange chromatography, from molecular recognition and electrostatic binding to selectivity, elution strategy, and impurity clearance.

CHROMATOGRAPHY

Chromatography Resin Ligands II

Chromatography Ligands are the molecular interface that determines how a chromatography resin recognizes, binds, and releases biomolecules.

Poster placeholder

CHROMATOGRAPHY

Poster Title 03

Replace this with a short excerpt from the LinkedIn post. Keep it to two or three lines so the card stays clean and consistent.

Poster placeholder

CHROMATOGRAPHY

Poster Title 04

Replace this with a short excerpt from the LinkedIn post. Keep it to two or three lines so the card stays clean and consistent.

Filtration & Separation

Clarification, depth filtration, sterile filtration, TFF/UFDF, virus filtration, centrifugation, and fouling.

FILTRATION & SEPARATION

Tangential Flow Filtration (TFF)

TFF is one of the most versatile and technically demanding unit operations in downstream processing. TFF can play different roles depending on the process: buffer exchange, concentration, desalting, volume reduction, product recovery, impurity removal, or even cell/particle retention.

FILTRATION & SEPARATION

Viral Clearance

Viruses are among the most critical potential contaminants in biopharmaceutical manufacturing because even low-level carryover can present a serious patient-safety risk.

Poster placeholder

FILTRATION & SEPARATION

Poster Title 03

Replace this with a short excerpt from the LinkedIn post. Keep it to two or three lines so the card stays clean and consistent.

Poster placeholder

FILTRATION & SEPARATION

Poster Title 04

Replace this with a short excerpt from the LinkedIn post. Keep it to two or three lines so the card stays clean and consistent.

Product Quality & Impurities

HCP, DNA, aggregates, residuals, product stability, impurity profiles, and characterization concepts.

PRODUCT QUALITY

Charge Variants in Biotherapeutics

During development, manufacturing, and storage, small chemical or enzymatic modifications can shift a therapeutic protein into acidic or basic hashtag#variants — changing its charge profile, stability, potency, or comparability.

PRODUCT QUALITY

Host Cell DNA

A few nanograms of residual DNA can carry major regulatory and process implications.

PRODUCT QUALITY

Process-Related Impurities

Replace this with a short excerpt from the LinkedIn post. Keep it to two or three lines so the card stays clean and consistent.

PRODUCT QUALITY

Hydrophobicity, Protein Folding & Aggregation

Hydrophobicity has two faces in protein stability: keep it buried, and it helps stabilize the fold; expose it, and it can become a driver of hashtag#aggregation.

Process Development & Manufacturing

DoE, high-throughput development, scale-up, tech transfer, continuous DSP, troubleshooting, and manufacturing reality.

PROCESS DEVELOPMENT

Purification Strategies for ADCs

Antibody–drug conjugate (ADC) pipelines are expanding fast, and Purification Strategy is becoming central to CMC robustness, product quality, and process success.

PROCESS DEVELOPMENT

Bispecific Antibodies Purification

Bispecific antibodies (bsAbs) are engineered to engage two targets—but their purification challenges often begin with the same structural complexity that enables their function.

PROCESS DEVELOPMENT

AAV Downstream Strategy

AAV is the tiny delivery vehicle powering some of gene therapy’s biggest ambitions.

PROCESS DEVELOPMENT

Therapeutic Peptide Purification

he world of Therapeutic Peptides is becoming increasingly compelling. From insulin and GLP_1 therapies to emerging treatments in oncology, cardiovascular disease, infectious disease, and rare disorders, peptides are expanding into a broad range of therapeutic areas. 

Stay Current

New insights, every two weeks.

Get new Purification Hub insights and visual learning content in your inbox.